JP Morgan Chase’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.4K Hold
11,043
﹤0.01% 6415
2025
Q4
$45.9K Sell
11,043
-4,427
-29% -$23.3K ﹤0.01% 6265
2025
Q3
$65.5K Buy
15,470
+3,133
+25% +$11.8K ﹤0.01% 6125
2025
Q2
$26K Sell
12,337
-4,628
-27% -$6.92K ﹤0.01% 6113
2025
Q1
$20.7K Sell
16,965
-42,728
-72% -$59.9K ﹤0.01% 6138
2024
Q4
$77K Buy
59,693
+29,065
+95% +$69.7K ﹤0.01% 5852
2024
Q3
$84.2K Buy
30,628
+18,907
+161% +$46.4K ﹤0.01% 5766
2024
Q2
$26.5K Buy
11,721
+9,850
+526% +$29.9K ﹤0.01% 6069
2024
Q1
$4.47K Buy
1,871
+48
+3% +$91 ﹤0.01% 6474
2023
Q4
$3.03K Buy
1,823
+1,730
+1,860% +$3.35K ﹤0.01% 6651
2023
Q3
$179 Buy
93
+50
+116% +$82 ﹤0.01% 6850
2023
Q2
$62 Hold
43
﹤0.01% 6732
2023
Q1
$0 Hold
43
﹤0.01% 6889
2022
Q4
$0 Hold
43
﹤0.01% 6710
2022
Q3
$0 Hold
43
﹤0.01% 6591
2022
Q2
$0 Hold
43
﹤0.01% 6618
2022
Q1
$0 Hold
43
﹤0.01% 6751
2021
Q4
$0 Hold
43
﹤0.01% 6754
2021
Q3
$0 Hold
43
﹤0.01% 6600
2021
Q2
$0 Sell
43
-100,512
-100% -$358K ﹤0.01% 6430
2021
Q1
$218K Sell
100,555
-3,158
-3% -$7.08K ﹤0.01% 5116
2020
Q4
$232K Buy
103,713
+82,039
+379% +$215K ﹤0.01% 4762
2020
Q3
$72K Sell
21,674
-6,337
-23% -$17.7K ﹤0.01% 4830
2020
Q2
$85K Sell
28,011
-12,588
-31% -$31.7K ﹤0.01% 4636
2020
Q1
$79K Buy
40,599
+27,467
+209% +$66.8K ﹤0.01% 4589
2019
Q4
$38K Hold
13,132
﹤0.01% 5199
2019
Q3
$48K Buy
13,132
+2,996
+30% +$10.8K ﹤0.01% 5192
2019
Q2
$41K Sell
10,136
-178,555
-95% -$773K ﹤0.01% 5249
2019
Q1
$964K Buy
+188,691
New +$906K ﹤0.01% 3828
2014
Q2
Sell
-10,745
Closed -$165K 3545
2014
Q1
$165K Buy
+10,745
New +$153K ﹤0.01% 3434

Other funds holding GALT